Ex­clu­sive: Cell­Cen­tric col­lects $120M to treat mul­ti­ple myelo­ma with a cap­sule

Cell­Cen­tric has raised a $120 mil­lion Se­ries C round to sup­port a po­ten­tial ac­cel­er­at­ed ap­proval in mul­ti­ple myelo­ma, the UK biotech ex­clu­sive­ly told End­points News …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER